6 Best Peptides for Metabolic Syndrome
Six peptides stand out in the research and real-world conversation around metabolic syndrome, ranging from FDA-approved incretin agonists with robust randomized controlled trial data to research-stage compounds whose mechanisms are well-described but whose human evidence is still emerging. Tirzepatide and semaglutide lead the field on clinical evidence, while MOTS-c, 5-Amino-1MQ, tesamorelin, and retatrutide each address distinct pieces of the syndrome through genuinely different pathways. The compounds here are ordered by how prominently each appears in published research and real-world use, not as a recommendation of one over another, and the personalized decision belongs in a conversation with a qualified provider and, when you are ready to map your options, inside the MyPeptidePal app.
